Cigna Corporation (CI)

186.67
3.70 2.00
NYSE
Prev Close 183.00
Open 185.00
Day Low/High 182.02 / 187.20
52 Wk Low/High 118.50 / 224.64
Volume 1.93M
Exchange NYSE
Shares Outstanding 367.20B
Market Cap 67.20B
P/E Ratio 13.02
Div & Yield N.A. (N.A)

Latest News

Trading Volumes Rising, GDP Forecasts, Earnings and Trading Thoughts

Trading Volumes Rising, GDP Forecasts, Earnings and Trading Thoughts

Market leadership may be lacking on Thursday despite rising trading volumes, plus an update on Apple, Microsoft, Mastercard, Amazon and Gilead.

Cigna Could Continue to Surge but Its Charts Are Not Totally Bullish

Cigna Could Continue to Surge but Its Charts Are Not Totally Bullish

The big insurer's technical indicators aren't conclusive as to the direction its shares will take in the coming weeks.

China Reduces Tariffs, 20 Year Treasury Bonds, Pricey Peloton: Market Recon

China Reduces Tariffs, 20 Year Treasury Bonds, Pricey Peloton: Market Recon

This move by Beijing comes on top of massive injections of liquidity into that nation's financial system earlier this week.

Drug Companies Are a Political Football, Trading Amgen: Market Recon

Drug Companies Are a Political Football, Trading Amgen: Market Recon

The nation enters an electoral season. The drug companies for the most part, have no friends on either side of the aisle.

Fed's Action, Consumer Remains Robust, Unimpressive Twilio: Market Recon

Fed's Action, Consumer Remains Robust, Unimpressive Twilio: Market Recon

I do think that this Fed Chair has learned to be cautious, in reflection of the policy errors made in late 2018.

Timing and Psychology Are Everything When Bargain Hunting

Timing and Psychology Are Everything When Bargain Hunting

When you're the most bummed out about how much you've lost, so is everybody else, and that's when they're willing to part with even the best stocks at really low prices.

Cigna Appears a Healthy Investment

Cigna Appears a Healthy Investment

With a discounted share price and health coverage proposals among politicians, there are multiple ways to play Cigna.

Jim Cramer: Welcome to a Market Filled With Fear

Jim Cramer: Welcome to a Market Filled With Fear

The impact of Elizabeth Warren is pretty much everywhere Thursday.

Powell's Verbal Fouls, an Equity Beatdown and Silence of the Lam: Market Recon

Powell's Verbal Fouls, an Equity Beatdown and Silence of the Lam: Market Recon

The Fed chairman's news conference threw markets for a loop with hawkish words that did not support the Fed's dovish actions.

A New Brand of Protest Emerges in Hong Kong

A New Brand of Protest Emerges in Hong Kong

A Japanese drink-maker, as well as Cigna and Yum! Brands' Pizza Hut, have been swept into the 'product politics' battle between pro-democracy demonstrators and pro-Mainland authorities.

European Debt Markets, Uninverting Curve, Facebook's Libra, Trading Costco

European Debt Markets, Uninverting Curve, Facebook's Libra, Trading Costco

This matters: Why the sudden 'weakness' across European debt markets?

Cigna Looks Poised for a Rally to Break 6-Month Decline

Cigna Looks Poised for a Rally to Break 6-Month Decline

The health services and insurance company appears ready to rally to the low $180-area.

Watching This Bearish Chart Pattern, and Why I Like Twilio Here: Market Recon

Watching This Bearish Chart Pattern, and Why I Like Twilio Here: Market Recon

For the major indices, Wednesday offered up a dangerous bearish reversal.

3 Top Healthcare Stocks Ripe For the Buying

3 Top Healthcare Stocks Ripe For the Buying

I've spotlighted three blue-chip companies with stock prices that are at ridiculously low valuations right now.

Chart of the Day: UNH's Universal Healthcare Comments Sting Sector

Chart of the Day: UNH's Universal Healthcare Comments Sting Sector

The free press that the progressive push for Medicare got on Tuesday morning is hurting the healthcare sector.

UnitedHealth Group Receives Booster Shot From Healthy Earnings, Outlook

UnitedHealth Group Receives Booster Shot From Healthy Earnings, Outlook

The health benefit giant's fundamentals are good, but there are more symptoms to consider for a proper examination.

The Global Macro-Economic Picture, China Watch, Keys to Amazon: Market Recon

The Global Macro-Economic Picture, China Watch, Keys to Amazon: Market Recon

The real takeaway for AMZN for me, and the main reason that I am even in the name on a semi-permanent basis, is AWS.

Jim Cramer: Why Wouldn't You Own Apple Stock?

Jim Cramer: Why Wouldn't You Own Apple Stock?

Has the sun set on what was the greatest wealth creator of any company when the stock traded north of a trillion dollars? No.

Real Money Post Industrial Average Outperformed the Market in 2018

Real Money Post Industrial Average Outperformed the Market in 2018

The RMPIA index was up for the year, while the S&P 500, DJIA, Russell 2000 and Nasdaq all finished 2018 in the red.

Jim Cramer: What to Buy in This Treacherous Market

Jim Cramer: What to Buy in This Treacherous Market

Look for the big-cap stocks that only come in on tough days -- and take advantage of their weakness at the open.

Jim Cramer: Why the Market Did What It Did Today and What Can Happen Tomorrow

Jim Cramer: Why the Market Did What It Did Today and What Can Happen Tomorrow

Now for those of you haven't voted, please go and do so and don't vote this stuff just invest in it!

Markets Are Headed For a More Difficult Environment: Market Recon

Markets Are Headed For a More Difficult Environment: Market Recon

Santa is on his way... A lot of pressure on the jolly fellow this year.

Jim Cramer: These Are the Stocks to Buy on Canada Deal and the 4th Quarter

Jim Cramer: These Are the Stocks to Buy on Canada Deal and the 4th Quarter

Straying from these names could land you in quicksand as the 4th quarter begins.

Cigna Rated New Overweight at Cantor

Jim Cramer: Valuations Now Have No Relation to Common Sense

Jim Cramer: Valuations Now Have No Relation to Common Sense

Analyst downgrades and mind-boggling P/E ratios do not matter in this current market.

Jim Cramer: These CEOs Deserve the Benefit of the Doubt

Jim Cramer: These CEOs Deserve the Benefit of the Doubt

Sometimes you gotta have faith, but you also have to be a little more skeptical.